CLINICIAN TESTIMONIALS
“This is the only test that could help me determine whether the root cause was of an infectious etiology or inflammatory.”
Dr. Eboni Cornish’s Testimonial
It’s helpful for not only the patient but the family to see that there really is an underlying inflammatory process actively occurring in this patient.
Dr. Eboni Cornish:
I find at times I’m always wondering if the root cause of their underlying neuropsychiatric symptoms are still more of an infectious etiology or if its more inflammatory and the neuropsychiatric condition needs to be addressed and the Cunningham Panel really helps me make that determination. I can look at those autoantibodies and get a better understanding of what is going on in that patient’s brain.
It also allows for me to get a better understanding of whether the infection is extremely active or if its on the version of resolving. So, I find it useful in knowing when and how I should change my management, as far as treatment for both the underlying infection or neuropsychiatric intervention. I also get an understanding of how active a person may be. So, that might require that I take a longer, more aggressive approach to a patient versus others.
I’m always wondering if the root cause of their underlying neuropsychiatric symptoms are still more of an infectious etiology or if its more inflammatory and the neuropsychiatric condition needs to be addressed and the Cunningham Panel really helps me make that determination.
And it is also helpful for not only the patient but the family to see that there really is an underlying inflammatory process actively occurring in this patient.
You can have patients who are chronically ill and they can be inflamed for numerous reasons. It can be environmental toxins, it can be current exposures or they’re unable to detox, or mold exposure, metals. Our society is way more toxic than it’s ever been.
So, when you’re thinking about that, you want to make sure you’re looking at root causes as it relates to underlying infections still being the primary target here. That’s why I find it [the Cunningham Panel] the most useful.
I look at all the autoantibodies [in the Cunningham Panel] of course and they do provide insight. But the utilization of this Panel for my patient population is more that I’m looking to see if this is an active infection, because my patient population are chronically sick.
So, they’ve seen 10 to 12 doctors minimally before they come into my office. They’ve been on treatments historically. They’ve been previously diagnosed. And I kind of doing the detective work to find out what might still be present.